Prakong Wichakanodom - Chularat Hospital Finance and Accounting Manager
CHG Stock | THB 2.64 0.04 1.54% |
Insider
Prakong Wichakanodom is Finance and Accounting Manager of Chularat Hospital Public since 2014.
Age | 59 |
Tenure | 10 years |
Phone | 66 2 033 2900 |
Web | https://www.chularat.com |
Chularat Hospital Management Efficiency
The company has return on total asset (ROA) of 0.3328 % which means that it generated a profit of $0.3328 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6521 %, meaning that it generated $0.6521 on every $100 dollars invested by stockholders. Chularat Hospital's management efficiency ratios could be used to measure how well Chularat Hospital manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Sukonrut Rungcharoenpong | AP Public | N/A | |
Poramaporn MD | Bangkok Dusit Medical | 52 | |
David FACHE | Bumrungrad Hospital Public | N/A | |
Daranee Bunchongsilp | Bangkok Dusit Medical | 41 | |
Supawan Sirinuntawit | Bumrungrad Hospital Public | N/A | |
Pipop Intaratut | BTS Group Holdings | 52 | |
Pramart Kwanchuen | AP Public | 48 | |
Surapant MD | Bangkok Chain Hospital | 59 | |
Pornsuda Harnphanich | Bangkok Chain Hospital | 34 | |
Puttipong PrasarttongOsoth | Bangkok Dusit Medical | 54 | |
Kantaporn MD | Bangkok Chain Hospital | 35 | |
Visanu Suchatlampong | AP Public | 61 | |
Daniel Kastner | Bumrungrad Hospital Public | N/A | |
Chairat MD | Bangkok Dusit Medical | 68 | |
Kultipa Tinnakornsrisupap | AP Public | 48 | |
Saifon Chaimongkol | Bangkok Chain Hospital | 52 | |
Jeremy Ford | Bumrungrad Hospital Public | N/A | |
Wason Naruenatpaisan | AP Public | 58 | |
Pornluck MD | Bangkok Chain Hospital | 37 | |
Tippawan Sirikoon | AP Public | 61 | |
Anuphong Assavabhokhin | AP Public | 61 |
Management Performance
Return On Equity | 0.65 | |||
Return On Asset | 0.33 |
Chularat Hospital Public Leadership Team
Elected by the shareholders, the Chularat Hospital's board of directors comprises two types of representatives: Chularat Hospital inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chularat. The board's role is to monitor Chularat Hospital's management team and ensure that shareholders' interests are well served. Chularat Hospital's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chularat Hospital's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kriangsak Plussind, Chairman of the Board | ||
Kannika Platsin, Director | ||
Manit Chiaradit, Director, Independent Director | ||
Kumpol MD, MD CEO | ||
Pinit Kullavanijaya, Non-Executive Independent Director | ||
Chutima Pinjaroen, Deputy Director | ||
Kannikar Plussind, Non-Executive Director | ||
Wichit Siritattamrong, Non-Executive Director | ||
Suchai Laowirawat, Managing Director, Executive Director, Director | ||
Yanyong Amornphithakkun, Director | ||
Kamphon Phlatsin, Chairman of the Executive Board, Managing Director, Director | ||
Chutima Pincharoen, Deputy Managing Director, Director - Chularat 11 International | ||
Somyot Yanubon, Director, Independent Director | ||
Kumpol Plussind, Chief Executive Officer, Managing Director, Executive Director | ||
Wandi Phisanuwanwet, Deputy Managing Director | ||
Yudthana Sanguansakdikosol, Deputy Managing Director, Director - Chularat 11 Hospital | ||
Somyos Yanubol, Non-Executive Independent Director | ||
Prakhong Wicharkkhanodom, Manager of Finance and Accounting | ||
Wandee Pisanuvanavech, Chief Financial Officer, Administrative Director, Company Secretary | ||
Suchai Laoveerawat, Executive Director, Hospital Director - Chularat 1, 3, 5 | ||
Yanyong Amornpitakkul, Non-Executive Director | ||
Phinit Kunlawanit, Director, Independent Director | ||
Yutthana Sanguansakkoson, Deputy Managing Director, Executive Director | ||
Wichit Sirithatthamrong, Director | ||
Korpkun Panyaphon, Director | ||
Chayawat Pisessith, Non-Executive Independent Director | ||
Kobkul Panyapol, Non-Executive Director | ||
Rasika Bangpong, Chief Mang | ||
Prakong Wichakanodom, Finance and Accounting Manager | ||
Aphirum Panyaphon, Non-Executive Director | ||
Suppachoke Rojcheewin, Chief Officer | ||
Kriangsak Phlatsin, Chairman of the Board | ||
Manit Jeeradit, Non-Executive Independent Director |
Chularat Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chularat Hospital a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.65 | |||
Return On Asset | 0.33 | |||
Profit Margin | 0.34 % | |||
Operating Margin | 0.44 % | |||
Current Valuation | 39.32 B | |||
Shares Outstanding | 11 B | |||
Shares Owned By Insiders | 57.00 % | |||
Shares Owned By Institutions | 5.11 % | |||
Price To Earning | 45.12 X | |||
Price To Book | 5.46 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Chularat Stock
Chularat Hospital financial ratios help investors to determine whether Chularat Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chularat with respect to the benefits of owning Chularat Hospital security.